Literature DB >> 8299719

Interactions between cells and collagen V molecules or single chains involve distinct mechanisms.

F Ruggiero1, M F Champliaud, R Garrone, M Aumailley.   

Abstract

Acid-soluble and pepsin-treated collagen V were prepared from fetal human bones or human placenta, respectively, to be tested for potential cell adhesion promoting activity. Out of 14 different collagen I-adhering cell lines, 10 showed distinct adhesion to collagen V. In all cases adhesion was followed by spreading. The activities of intact and pepsin-solubilized collagen V were similar, suggesting that the cell binding sites are restricted to the triple-helical domain of the molecules. Cell adhesion was also induced by the unfolded form of collagen V and after separation of the alpha chains by heparin affinity chromatography. Isolated alpha 2(V) chains, rich in RGD sequences, were more efficient than isolated alpha 1(V) chains. However, cell adhesion to native or denatured collagen V did not proceed by the same molecular mechanisms as shown by cell adhesion inhibition experiments. Cell adhesion to native collagen V was insensitive to the presence of RGD-containing synthetic peptides while adhesion to denatured collagen V was inhibited by the peptides. Furthermore, the results strongly suggested a major role for alpha 1 beta 1 and alpha 2 beta 1 integrins in the RGD-independent cell adhesion to native collagen V. These data indicate that collagen V is a specific adhesive substrate for different cell types. It also suggests that distinct sets of RGD-dependent and RGD-independent receptors mediate cell attachment to unfolded and native collagen V, respectively. This mechanism is shared by at least the interstitial collagens I and VI, which supports the hypothesis that when included in the triple-helical conformation of collagens, RGD sequences are either not accessible to cells or exhibit specific conformations recognized by different integrins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299719     DOI: 10.1006/excr.1994.1032

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Development of a functional skin matrix requires deposition of collagen V heterotrimers.

Authors:  Hélène Chanut-Delalande; Christelle Bonod-Bidaud; Sylvain Cogne; Marilyne Malbouyres; Francesco Ramirez; Agnès Fichard; Florence Ruggiero
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins alpha2beta1 and alpha11beta1.

Authors:  Clayton C Caswell; Malgorzata Barczyk; Douglas R Keene; Ewa Lukomska; Donald E Gullberg; Slawomir Lukomski
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

3.  Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior.

Authors:  Edwin Roger Parra; Leonardo Cavallari Bielecki; José Mauro da Fonseca Pestana Ribeiro; Fernando de Andrade Balsalobre; Walcy R Teodoro; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

4.  Osteoblast Differentiation on Collagen Scaffold with Immobilized Alkaline Phosphatase.

Authors:  F Jafary; P Hanachi; K Gorjipour
Journal:  Int J Organ Transplant Med       Date:  2017-11-01

5.  Post-Adipose-Derived Stem Cells (ADSC) Stimulated by Collagen Type V (Col V) Mitigate the Progression of Osteoarthritic Rabbit Articular Cartilage.

Authors:  Isabele Camargo Brindo da Cruz; Ana Paula Pereira Velosa; Solange Carrasco; Antonio Dos Santos Filho; Jurandir Tomaz de Miranda; Eduardo Pompeu; Tiago Lazzaretti Fernandes; Daniela Franco Bueno; Camila Fanelli; Cláudia Goldenstein-Schainberg; Alexandre Todorovic Fabro; Ricardo Fuller; Pedro Leme Silva; Vera Luiza Capelozzi; Walcy Rosolia Teodoro
Journal:  Front Cell Dev Biol       Date:  2021-03-22

6.  Circulating levels of a collagen type v propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis.

Authors:  E Vassiliadis; S S Veidal; C Hansen; M A Karsdal; D J Leeming
Journal:  Biomark Insights       Date:  2012-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.